Equity Capital Markets

Company · CIK 2025942

Curanex Pharmaceuticals Inc

CIK2025942 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inNV
Business addressNY
ListedCURX (Nasdaq)
First annual or quarterly report2025-09-09

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-282686
IPOFinal prospectus
 2024-10-162025-08-2610

Filings

11
FiledFilingRegistrationAccession
2025-08-26424B4Final prospectus 333-2826860001493152-25-012351
2025-08-26424B4Final prospectus 333-2826860001493152-25-012350
2025-08-12EFFECTDeclared effective 333-2826869999999995-25-002569
2025-07-18S-1/AAmendment 333-2826860001641172-25-020262
2025-07-01S-1/AAmendment 333-2826860001641172-25-017373
2025-03-17S-1/AAmendment 333-2826860001493152-25-010520
2025-02-14S-1/AAmendment 333-2826860001493152-25-006655
2024-11-27S-1/AAmendment 333-2826860001493152-24-048072
2024-11-01S-1/AAmendment 333-2826860001493152-24-043386
2024-10-16S-1Registration filed 333-2826860001493152-24-041335
2024-06-20DRSDraft made public 377-072900001493152-24-024532

All filings of this company · CSV